科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/09/16 | 6,030 | 6,160 | 6,010 | 6,140 | +150 | +2.5% | 128,700 |
| 2016/09/15 | 5,910 | 6,010 | 5,910 | 5,990 | +70 | +1.2% | 122,500 |
| 2016/09/14 | 5,970 | 5,980 | 5,910 | 5,920 | -70 | -1.2% | 111,700 |
| 2016/09/13 | 5,970 | 6,020 | 5,940 | 5,990 | +120 | +2% | 114,200 |
| 2016/09/12 | 5,880 | 5,960 | 5,860 | 5,870 | -70 | -1.2% | 134,900 |
| 2016/09/09 | 6,050 | 6,060 | 5,930 | 5,940 | -110 | -1.8% | 127,300 |
| 2016/09/08 | 5,950 | 6,060 | 5,910 | 6,050 | +110 | +1.9% | 163,900 |
| 2016/09/07 | 5,940 | 6,020 | 5,930 | 5,940 | ±0 | ±0% | 147,600 |
| 2016/09/06 | 5,840 | 5,960 | 5,820 | 5,940 | +100 | +1.7% | 128,200 |
| 2016/09/05 | 6,050 | 6,080 | 5,820 | 5,840 | -190 | -3.2% | 192,900 |
| 2016/09/02 | 5,950 | 6,040 | 5,950 | 6,030 | +90 | +1.5% | 103,600 |
| 2016/09/01 | 5,850 | 5,970 | 5,820 | 5,940 | +100 | +1.7% | 135,100 |
| 2016/08/31 | 5,850 | 5,860 | 5,780 | 5,840 | +30 | +0.5% | 135,000 |
| 2016/08/30 | 5,860 | 5,870 | 5,800 | 5,810 | -120 | -2% | 141,900 |
| 2016/08/29 | 6,090 | 6,090 | 5,900 | 5,930 | +10 | +0.2% | 105,500 |
| 2016/08/26 | 6,000 | 6,010 | 5,900 | 5,920 | -160 | -2.6% | 132,600 |
| 2016/08/25 | 6,050 | 6,100 | 6,020 | 6,080 | +30 | +0.5% | 139,300 |
| 2016/08/24 | 6,040 | 6,170 | 5,990 | 6,050 | +110 | +1.9% | 193,900 |
| 2016/08/23 | 5,800 | 5,990 | 5,800 | 5,940 | +100 | +1.7% | 171,000 |
| 2016/08/22 | 5,900 | 5,950 | 5,790 | 5,840 | -60 | -1% | 242,400 |
| 2016/08/19 | 5,910 | 5,980 | 5,860 | 5,900 | -110 | -1.8% | 155,000 |
| 2016/08/18 | 6,100 | 6,180 | 5,990 | 6,010 | -130 | -2.1% | 192,500 |
| 2016/08/17 | 6,140 | 6,180 | 6,080 | 6,140 | +40 | +0.7% | 219,600 |
| 2016/08/16 | 6,250 | 6,260 | 6,100 | 6,100 | -170 | -2.7% | 240,200 |
| 2016/08/15 | 6,440 | 6,540 | 6,260 | 6,270 | -260 | -4% | 178,900 |
| 2016/08/12 | 6,570 | 6,570 | 6,460 | 6,530 | +60 | +0.9% | 161,400 |
| 2016/08/10 | 6,420 | 6,520 | 6,400 | 6,470 | +50 | +0.8% | 149,000 |
| 2016/08/09 | 6,330 | 6,430 | 6,300 | 6,420 | +130 | +2.1% | 200,900 |
| 2016/08/08 | 6,200 | 6,320 | 6,180 | 6,290 | +190 | +3.1% | 299,900 |
| 2016/08/05 | 6,450 | 6,450 | 6,030 | 6,100 | -260 | -4.1% | 366,200 |
| 2016/08/04 | 6,520 | 6,590 | 6,310 | 6,360 | +10 | +0.2% | 282,900 |
| 2016/08/03 | 6,590 | 6,650 | 6,260 | 6,350 | -340 | -5.1% | 396,400 |
| 2016/08/02 | 6,820 | 6,900 | 6,670 | 6,690 | -210 | -3% | 171,600 |
| 2016/08/01 | 6,690 | 6,930 | 6,690 | 6,900 | +70 | +1% | 183,000 |
| 2016/07/29 | 6,730 | 6,850 | 6,690 | 6,830 | +170 | +2.6% | 287,600 |
| 2016/07/28 | 6,980 | 7,030 | 6,630 | 6,660 | -340 | -4.9% | 345,100 |
| 2016/07/27 | 7,130 | 7,130 | 6,980 | 7,000 | -110 | -1.5% | 180,900 |
| 2016/07/26 | 7,050 | 7,150 | 7,050 | 7,110 | +80 | +1.1% | 186,100 |
| 2016/07/25 | 6,960 | 7,150 | 6,880 | 7,030 | +70 | +1% | 215,500 |
| 2016/07/22 | 7,010 | 7,090 | 6,900 | 6,960 | -50 | -0.7% | 173,100 |
| 2016/07/21 | 7,060 | 7,060 | 6,930 | 7,010 | ±0 | ±0% | 236,700 |
| 2016/07/20 | 6,950 | 7,050 | 6,910 | 7,010 | +70 | +1% | 235,100 |
| 2016/07/19 | 6,830 | 6,940 | 6,770 | 6,940 | +130 | +1.9% | 336,900 |
| 2016/07/15 | 7,070 | 7,080 | 6,780 | 6,810 | -230 | -3.3% | 324,900 |
| 2016/07/14 | 6,960 | 7,140 | 6,880 | 7,040 | +20 | +0.3% | 255,100 |
| 2016/07/13 | 7,220 | 7,250 | 6,990 | 7,020 | -120 | -1.7% | 363,000 |
| 2016/07/12 | 7,250 | 7,280 | 7,120 | 7,140 | ±0 | ±0% | 289,100 |
| 2016/07/11 | 7,060 | 7,170 | 7,030 | 7,140 | +240 | +3.5% | 203,300 |
| 2016/07/08 | 7,010 | 7,140 | 6,870 | 6,900 | -70 | -1% | 250,800 |
| 2016/07/07 | 6,970 | 7,010 | 6,900 | 6,970 | +30 | +0.4% | 188,600 |
2101～
2150
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 404,900円 | +30.5% | +111.0% | 4.69% | 11.41倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 360,700円 | +7.9% | +8.9% | 3.44% | 7.72倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 193,100円 | +5.0% | +1.5% | 0.00% | 16.58倍 | 4.41倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 377,500円 | +14.5% | -2.3% | 2.38% | 13.81倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 189,800円 | - | - | 0.00% | - | 87.91倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
